カテゴリー： Market Monitor Global, 世界, 医療/バイオ

視神経炎治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Optic Neuritis Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5836）

◆商品コード：MMG23JU5836
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Optic Neuritis Drug Market 調査レポートは次の情報を含め、グローバルにおけるの視神経炎治療薬市場規模と予測を収録しています。・世界の視神経炎治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の視神経炎治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の視神経炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口ステロイド薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

視神経炎治療薬のグローバル主要企業は、Sicor Societa' Italiana Corticosteroidi S.R.L、 Allergan Pharmaceuticals Ireland、 NANG KUANG PHARMACEUTICAL、 PFIZER SA、 NEWCHEM SPA、 BIOFER S.P.A、 Shandong Xinhua Pharmaceutical、 Shanghai General Pharmaceutical、 HPGC、 CR Zizhuなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、視神経炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の視神経炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の視神経炎治療薬市場：タイプ別市場シェア、2022年
・経口ステロイド薬、静脈内ステロイド薬、その他

世界の視神経炎治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の視神経炎治療薬市場：用途別市場シェア、2022年
・大人、子供

世界の視神経炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の視神経炎治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における視神経炎治療薬のグローバル売上、2018年-2023年
・主要企業における視神経炎治療薬のグローバル売上シェア、2022年
・主要企業における視神経炎治療薬のグローバル販売量、2018年-2023年
・主要企業における視神経炎治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sicor Societa' Italiana Corticosteroidi S.R.L、 Allergan Pharmaceuticals Ireland、 NANG KUANG PHARMACEUTICAL、 PFIZER SA、 NEWCHEM SPA、 BIOFER S.P.A、 Shandong Xinhua Pharmaceutical、 Shanghai General Pharmaceutical、 HPGC、 CR Zizhu

*************************************************************

・調査・分析レポートの概要
視神経炎治療薬市場の定義
市場セグメント
世界の視神経炎治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の視神経炎治療薬市場規模
世界の視神経炎治療薬市場規模：2022年 VS 2029年
世界の視神経炎治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの視神経炎治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の視神経炎治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口ステロイド薬、静脈内ステロイド薬、その他
視神経炎治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
視神経炎治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別視神経炎治療薬市場規模 2022年と2029年
地域別視神経炎治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sicor Societa' Italiana Corticosteroidi S.R.L、 Allergan Pharmaceuticals Ireland、 NANG KUANG PHARMACEUTICAL、 PFIZER SA、 NEWCHEM SPA、 BIOFER S.P.A、 Shandong Xinhua Pharmaceutical、 Shanghai General Pharmaceutical、 HPGC、 CR Zizhu
...

This report aims to provide a comprehensive presentation of the global market for Optic Neuritis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optic Neuritis Drug. This report contains market size and forecasts of Optic Neuritis Drug in global, including the following market information:
Global Optic Neuritis Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Optic Neuritis Drug Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Optic Neuritis Drug companies in 2022 (%)
The global Optic Neuritis Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral corticosteroid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Optic Neuritis Drug include Sicor Societa’ Italiana Corticosteroidi S.R.L, Allergan Pharmaceuticals Ireland, NANG KUANG PHARMACEUTICAL, PFIZER SA, NEWCHEM SPA, BIOFER S.P.A, Shandong Xinhua Pharmaceutical, Shanghai General Pharmaceutical and HPGC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Optic Neuritis Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Optic Neuritis Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Optic Neuritis Drug Market Segment Percentages, by Type, 2022 (%)
Oral corticosteroid
Intravenous corticosteroid
Other
Global Optic Neuritis Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Optic Neuritis Drug Market Segment Percentages, by Application, 2022 (%)
Adult
Children
Global Optic Neuritis Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Optic Neuritis Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Optic Neuritis Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Optic Neuritis Drug revenues share in global market, 2022 (%)
Key companies Optic Neuritis Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Optic Neuritis Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sicor Societa’ Italiana Corticosteroidi S.R.L
Allergan Pharmaceuticals Ireland
NANG KUANG PHARMACEUTICAL
PFIZER SA
NEWCHEM SPA
BIOFER S.P.A
Shandong Xinhua Pharmaceutical
Shanghai General Pharmaceutical
HPGC
CR Zizhu
Outline of Major Chapters:
Chapter 1: Introduces the definition of Optic Neuritis Drug, market overview.
Chapter 2: Global Optic Neuritis Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Optic Neuritis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Optic Neuritis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Optic Neuritis Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Optic Neuritis Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Optic Neuritis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Optic Neuritis Drug Overall Market Size
2.1 Global Optic Neuritis Drug Market Size: 2022 VS 2029
2.2 Global Optic Neuritis Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Optic Neuritis Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Optic Neuritis Drug Players in Global Market
3.2 Top Global Optic Neuritis Drug Companies Ranked by Revenue
3.3 Global Optic Neuritis Drug Revenue by Companies
3.4 Global Optic Neuritis Drug Sales by Companies
3.5 Global Optic Neuritis Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Optic Neuritis Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Optic Neuritis Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Optic Neuritis Drug Players in Global Market
3.8.1 List of Global Tier 1 Optic Neuritis Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Optic Neuritis Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Optic Neuritis Drug Market Size Markets, 2022 & 2029
4.1.2 Oral corticosteroid
4.1.3 Intravenous corticosteroid
4.1.4 Other
4.2 By Type – Global Optic Neuritis Drug Revenue & Forecasts
4.2.1 By Type – Global Optic Neuritis Drug Revenue, 2018-2023
4.2.2 By Type – Global Optic Neuritis Drug Revenue, 2024-2029
4.2.3 By Type – Global Optic Neuritis Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Optic Neuritis Drug Sales & Forecasts
4.3.1 By Type – Global Optic Neuritis Drug Sales, 2018-2023
4.3.2 By Type – Global Optic Neuritis Drug Sales, 2024-2029
4.3.3 By Type – Global Optic Neuritis Drug Sales Market Share, 2018-2029
4.4 By Type – Global Optic Neuritis Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Optic Neuritis Drug Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Children
5.2 By Application – Global Optic Neuritis Drug Revenue & Forecasts
5.2.1 By Application – Global Optic Neuritis Drug Revenue, 2018-2023
5.2.2 By Application – Global Optic Neuritis Drug Revenue, 2024-2029
5.2.3 By Application – Global Optic Neuritis Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Optic Neuritis Drug Sales & Forecasts
5.3.1 By Application – Global Optic Neuritis Drug Sales, 2018-2023
5.3.2 By Application – Global Optic Neuritis Drug Sales, 2024-2029
5.3.3 By Application – Global Optic Neuritis Drug Sales Market Share, 2018-2029
5.4 By Application – Global Optic Neuritis Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Optic Neuritis Drug Market Size, 2022 & 2029
6.2 By Region – Global Optic Neuritis Drug Revenue & Forecasts
6.2.1 By Region – Global Optic Neuritis Drug Revenue, 2018-2023
6.2.2 By Region – Global Optic Neuritis Drug Revenue, 2024-2029
6.2.3 By Region – Global Optic Neuritis Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Optic Neuritis Drug Sales & Forecasts
6.3.1 By Region – Global Optic Neuritis Drug Sales, 2018-2023
6.3.2 By Region – Global Optic Neuritis Drug Sales, 2024-2029
6.3.3 By Region – Global Optic Neuritis Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Optic Neuritis Drug Revenue, 2018-2029
6.4.2 By Country – North America Optic Neuritis Drug Sales, 2018-2029
6.4.3 US Optic Neuritis Drug Market Size, 2018-2029
6.4.4 Canada Optic Neuritis Drug Market Size, 2018-2029
6.4.5 Mexico Optic Neuritis Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Optic Neuritis Drug Revenue, 2018-2029
6.5.2 By Country – Europe Optic Neuritis Drug Sales, 2018-2029
6.5.3 Germany Optic Neuritis Drug Market Size, 2018-2029
6.5.4 France Optic Neuritis Drug Market Size, 2018-2029
6.5.5 U.K. Optic Neuritis Drug Market Size, 2018-2029
6.5.6 Italy Optic Neuritis Drug Market Size, 2018-2029
6.5.7 Russia Optic Neuritis Drug Market Size, 2018-2029
6.5.8 Nordic Countries Optic Neuritis Drug Market Size, 2018-2029
6.5.9 Benelux Optic Neuritis Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Optic Neuritis Drug Revenue, 2018-2029
6.6.2 By Region – Asia Optic Neuritis Drug Sales, 2018-2029
6.6.3 China Optic Neuritis Drug Market Size, 2018-2029
6.6.4 Japan Optic Neuritis Drug Market Size, 2018-2029
6.6.5 South Korea Optic Neuritis Drug Market Size, 2018-2029
6.6.6 Southeast Asia Optic Neuritis Drug Market Size, 2018-2029
6.6.7 India Optic Neuritis Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Optic Neuritis Drug Revenue, 2018-2029
6.7.2 By Country – South America Optic Neuritis Drug Sales, 2018-2029
6.7.3 Brazil Optic Neuritis Drug Market Size, 2018-2029
6.7.4 Argentina Optic Neuritis Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Optic Neuritis Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Optic Neuritis Drug Sales, 2018-2029
6.8.3 Turkey Optic Neuritis Drug Market Size, 2018-2029
6.8.4 Israel Optic Neuritis Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Optic Neuritis Drug Market Size, 2018-2029
6.8.6 UAE Optic Neuritis Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sicor Societa’ Italiana Corticosteroidi S.R.L
7.1.1 Sicor Societa’ Italiana Corticosteroidi S.R.L Company Summary
7.1.2 Sicor Societa’ Italiana Corticosteroidi S.R.L Business Overview
7.1.3 Sicor Societa’ Italiana Corticosteroidi S.R.L Optic Neuritis Drug Major Product Offerings
7.1.4 Sicor Societa’ Italiana Corticosteroidi S.R.L Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.1.5 Sicor Societa’ Italiana Corticosteroidi S.R.L Key News & Latest Developments
7.2 Allergan Pharmaceuticals Ireland
7.2.1 Allergan Pharmaceuticals Ireland Company Summary
7.2.2 Allergan Pharmaceuticals Ireland Business Overview
7.2.3 Allergan Pharmaceuticals Ireland Optic Neuritis Drug Major Product Offerings
7.2.4 Allergan Pharmaceuticals Ireland Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Pharmaceuticals Ireland Key News & Latest Developments
7.3 NANG KUANG PHARMACEUTICAL
7.3.1 NANG KUANG PHARMACEUTICAL Company Summary
7.3.2 NANG KUANG PHARMACEUTICAL Business Overview
7.3.3 NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Major Product Offerings
7.3.4 NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.3.5 NANG KUANG PHARMACEUTICAL Key News & Latest Developments
7.4 PFIZER SA
7.4.1 PFIZER SA Company Summary
7.4.2 PFIZER SA Business Overview
7.4.3 PFIZER SA Optic Neuritis Drug Major Product Offerings
7.4.4 PFIZER SA Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.4.5 PFIZER SA Key News & Latest Developments
7.5 NEWCHEM SPA
7.5.1 NEWCHEM SPA Company Summary
7.5.2 NEWCHEM SPA Business Overview
7.5.3 NEWCHEM SPA Optic Neuritis Drug Major Product Offerings
7.5.4 NEWCHEM SPA Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.5.5 NEWCHEM SPA Key News & Latest Developments
7.6 BIOFER S.P.A
7.6.1 BIOFER S.P.A Company Summary
7.6.2 BIOFER S.P.A Business Overview
7.6.3 BIOFER S.P.A Optic Neuritis Drug Major Product Offerings
7.6.4 BIOFER S.P.A Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.6.5 BIOFER S.P.A Key News & Latest Developments
7.7 Shandong Xinhua Pharmaceutical
7.7.1 Shandong Xinhua Pharmaceutical Company Summary
7.7.2 Shandong Xinhua Pharmaceutical Business Overview
7.7.3 Shandong Xinhua Pharmaceutical Optic Neuritis Drug Major Product Offerings
7.7.4 Shandong Xinhua Pharmaceutical Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.7.5 Shandong Xinhua Pharmaceutical Key News & Latest Developments
7.8 Shanghai General Pharmaceutical
7.8.1 Shanghai General Pharmaceutical Company Summary
7.8.2 Shanghai General Pharmaceutical Business Overview
7.8.3 Shanghai General Pharmaceutical Optic Neuritis Drug Major Product Offerings
7.8.4 Shanghai General Pharmaceutical Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.8.5 Shanghai General Pharmaceutical Key News & Latest Developments
7.9 HPGC
7.9.1 HPGC Company Summary
7.9.2 HPGC Business Overview
7.9.3 HPGC Optic Neuritis Drug Major Product Offerings
7.9.4 HPGC Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.9.5 HPGC Key News & Latest Developments
7.10 CR Zizhu
7.10.1 CR Zizhu Company Summary
7.10.2 CR Zizhu Business Overview
7.10.3 CR Zizhu Optic Neuritis Drug Major Product Offerings
7.10.4 CR Zizhu Optic Neuritis Drug Sales and Revenue in Global (2018-2023)
7.10.5 CR Zizhu Key News & Latest Developments
8 Global Optic Neuritis Drug Production Capacity, Analysis
8.1 Global Optic Neuritis Drug Production Capacity, 2018-2029
8.2 Optic Neuritis Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Optic Neuritis Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Optic Neuritis Drug Supply Chain Analysis
10.1 Optic Neuritis Drug Industry Value Chain
10.2 Optic Neuritis Drug Upstream Market
10.3 Optic Neuritis Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Optic Neuritis Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Optic Neuritis Drug in Global Market
Table 2. Top Optic Neuritis Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Optic Neuritis Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Optic Neuritis Drug Revenue Share by Companies, 2018-2023
Table 5. Global Optic Neuritis Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Optic Neuritis Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Optic Neuritis Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Optic Neuritis Drug Product Type
Table 9. List of Global Tier 1 Optic Neuritis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Optic Neuritis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Optic Neuritis Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Optic Neuritis Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Optic Neuritis Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Optic Neuritis Drug Sales (K Pcs), 2024-2029
Table 16. By Application – Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Optic Neuritis Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Optic Neuritis Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Optic Neuritis Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Optic Neuritis Drug Sales (K Pcs), 2024-2029
Table 21. By Region – Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Optic Neuritis Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Optic Neuritis Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Optic Neuritis Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Optic Neuritis Drug Sales (K Pcs), 2024-2029
Table 26. By Country - North America Optic Neuritis Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Optic Neuritis Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Optic Neuritis Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Optic Neuritis Drug Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Optic Neuritis Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Optic Neuritis Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Optic Neuritis Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Optic Neuritis Drug Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Optic Neuritis Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Optic Neuritis Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Optic Neuritis Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Optic Neuritis Drug Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Optic Neuritis Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Optic Neuritis Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Optic Neuritis Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Optic Neuritis Drug Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Optic Neuritis Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Optic Neuritis Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Optic Neuritis Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Optic Neuritis Drug Sales, (K Pcs), 2024-2029
Table 46. Sicor Societa' Italiana Corticosteroidi S.R.L Company Summary
Table 47. Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Product Offerings
Table 48. Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Sicor Societa' Italiana Corticosteroidi S.R.L Key News & Latest Developments
Table 50. Allergan Pharmaceuticals Ireland Company Summary
Table 51. Allergan Pharmaceuticals Ireland Optic Neuritis Drug Product Offerings
Table 52. Allergan Pharmaceuticals Ireland Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Allergan Pharmaceuticals Ireland Key News & Latest Developments
Table 54. NANG KUANG PHARMACEUTICAL Company Summary
Table 55. NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Product Offerings
Table 56. NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. NANG KUANG PHARMACEUTICAL Key News & Latest Developments
Table 58. PFIZER SA Company Summary
Table 59. PFIZER SA Optic Neuritis Drug Product Offerings
Table 60. PFIZER SA Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. PFIZER SA Key News & Latest Developments
Table 62. NEWCHEM SPA Company Summary
Table 63. NEWCHEM SPA Optic Neuritis Drug Product Offerings
Table 64. NEWCHEM SPA Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. NEWCHEM SPA Key News & Latest Developments
Table 66. BIOFER S.P.A Company Summary
Table 67. BIOFER S.P.A Optic Neuritis Drug Product Offerings
Table 68. BIOFER S.P.A Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. BIOFER S.P.A Key News & Latest Developments
Table 70. Shandong Xinhua Pharmaceutical Company Summary
Table 71. Shandong Xinhua Pharmaceutical Optic Neuritis Drug Product Offerings
Table 72. Shandong Xinhua Pharmaceutical Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Shandong Xinhua Pharmaceutical Key News & Latest Developments
Table 74. Shanghai General Pharmaceutical Company Summary
Table 75. Shanghai General Pharmaceutical Optic Neuritis Drug Product Offerings
Table 76. Shanghai General Pharmaceutical Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Shanghai General Pharmaceutical Key News & Latest Developments
Table 78. HPGC Company Summary
Table 79. HPGC Optic Neuritis Drug Product Offerings
Table 80. HPGC Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. HPGC Key News & Latest Developments
Table 82. CR Zizhu Company Summary
Table 83. CR Zizhu Optic Neuritis Drug Product Offerings
Table 84. CR Zizhu Optic Neuritis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. CR Zizhu Key News & Latest Developments
Table 86. Optic Neuritis Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Optic Neuritis Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Optic Neuritis Drug Production by Region, 2018-2023 (K Pcs)
Table 89. Global Optic Neuritis Drug Production by Region, 2024-2029 (K Pcs)
Table 90. Optic Neuritis Drug Market Opportunities & Trends in Global Market
Table 91. Optic Neuritis Drug Market Drivers in Global Market
Table 92. Optic Neuritis Drug Market Restraints in Global Market
Table 93. Optic Neuritis Drug Raw Materials
Table 94. Optic Neuritis Drug Raw Materials Suppliers in Global Market
Table 95. Typical Optic Neuritis Drug Downstream
Table 96. Optic Neuritis Drug Downstream Clients in Global Market
Table 97. Optic Neuritis Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Optic Neuritis Drug Segment by Type in 2022
Figure 2. Optic Neuritis Drug Segment by Application in 2022
Figure 3. Global Optic Neuritis Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Optic Neuritis Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Optic Neuritis Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Optic Neuritis Drug Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Optic Neuritis Drug Revenue in 2022
Figure 9. By Type - Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Optic Neuritis Drug Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Optic Neuritis Drug Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Optic Neuritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Optic Neuritis Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 23. US Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 28. Germany Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 37. China Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 44. Brazil Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Optic Neuritis Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Optic Neuritis Drug Sales Market Share, 2018-2029
Figure 48. Turkey Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Optic Neuritis Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Optic Neuritis Drug Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Optic Neuritis Drug by Region, 2022 VS 2029
Figure 54. Optic Neuritis Drug Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 視神経炎治療薬の世界市場見通し2023年-2029年(Optic Neuritis Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

視神経炎治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp